Eric Bjerkholt - Nov 8, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Nov 8, 2024
Transactions value $
$9,997
Form type
4
Date filed
11/14/2024, 04:34 PM
Previous filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $10K +475 +1.45% $21.05 33.3K Nov 8, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 475 shares by the Reporting Person on November 8, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.